(Q46155965)

20 December 2017

title

Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study (English)

1 reference

20 December 2017

medroxyprogesterone acetate

main subject

endometrial hyperplasia

1 reference

based on heuristic

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Mohamed Emarh

series ordinal

1

1 reference

20 December 2017

publication date

27 May 2015

1 reference

20 December 2017

Archives of Gynecology and Obstetrics

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1339-1343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00404-015-3749-3

12 June 2020

exact match

0 references

cites work

The management of endometrial hyperplasia: an evaluation of current practice

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Resistance to chemotherapy and hormone therapy in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Predictive diagnosis of endometrial hyperplasia and personalized therapeutic strategy in women of fertile age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3749-3

10.1007/S00404-015-3749-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26015309%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference